NCT01801527

Brief Summary

Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style. Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program. Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care. Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2013

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 28, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

1.9 years

First QC Date

February 27, 2013

Last Update Submit

October 25, 2017

Conditions

Keywords

TelehealthFatigueBreast cancerExerciseQuality of lifeTelerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Quality of life

    The primary outcome will be assessed with The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) version 3.0. This questionnaire includes both multi-item scales and single-item measures. These are composed by five functional scales, three symptom scales, a global health status/QoL scale, and six single items. The scores have to be averaged and transformed linearly to obtain a range of score from 0 to 100 where high score meaning a great response level. The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23) which is a breast cancer module of EORTC QLQ-C30 will also be assessed

    Participants will be followed over 8 weeks

Secondary Outcomes (10)

  • Algometry

    Participants will be followed over 8 weeks

  • The Visual Analogue Scale (VAS) for pain

    Participants will be followed over 8 weeks

  • Pain

    Participants will be followed over 8 weeks

  • Body composition

    Participants will be followed over 8 weeks

  • Physical measurement

    Participants will be followed over 8 weeks

  • +5 more secondary outcomes

Study Arms (2)

Telerehabilitation group

EXPERIMENTAL
Behavioral: Telerehabilitation group

Control group

NO INTERVENTION

Information about usual care

Interventions

Interventions will be based on to provide cardiovascular, mobility, strength and stretching exercises through telerehabilitation system

Telerehabilitation group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stage I, II, or IIIA breast cancer
  • Medical clearance of participation
  • Without chronic disease or orthopaedic that would interfere with ability to participate in a physical activity program
  • Access to Internet
  • Basic ability to use the computer or living with a relative who has this ability
  • Completion of adjuvant therapy except for hormone therapy
  • No history of cancer recurrence
  • Have interest in improving lifestyle: fitness/stress level
  • Have signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences. University of Granada

Granada, 18071, Spain

Location

Related Publications (2)

  • Galiano-Castillo N, Arroyo-Morales M, Ariza-Garcia A, Fernandez-Lao C, Fernandez-Fernandez AJ, Cantarero-Villanueva I. Factors that Explain the Cancer-Related Insomnia. Breast J. 2017 Jul;23(4):387-394. doi: 10.1111/tbj.12759. Epub 2017 Jan 24.

  • Galiano-Castillo N, Ariza-Garcia A, Cantarero-Villanueva I, Fernandez-Lao C, Diaz-Rodriguez L, Legeren-Alvarez M, Sanchez-Salado C, Del-Moral-Avila R, Arroyo-Morales M. Telehealth system (e-CUIDATE) to improve quality of life in breast cancer survivors: rationale and study protocol for a randomized clinical trial. Trials. 2013 Jun 22;14:187. doi: 10.1186/1745-6215-14-187.

MeSH Terms

Conditions

Breast NeoplasmsFatigueMotor Activity

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Manuel Arroyo-Morales, PhD

    Faculty of Health Sciences. University of Granada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

February 27, 2013

First Posted

February 28, 2013

Study Start

March 1, 2012

Primary Completion

February 1, 2014

Study Completion

July 1, 2014

Last Updated

October 27, 2017

Record last verified: 2017-10

Locations